15 Most Shorted Stocks Right Now on Wall Street

Published on March 3, 2023 at 11:40 am by Omer Farooq in Hedge Funds, News

In this article, we will look at the 15 most shorted stocks on Wall Street right now. If you want to explore similar stocks, you can also take a look at 5 Most Shorted Stocks Right Now on Wall Street.

Short selling is a way for traders to make money by betting that the price of a stock will go down. It involves selling borrowed shares of a company in the hopes that the price will go down before the investor must return them. If the price does go down, the investor can buy back the shares at a lower price and pocket the difference. It is important to remember that short selling is a risky strategy and should only be used by experienced investors.

Analyst’s Take on Shorted Stocks

On February 27 S3 Partners Head of Predictive Analytics, Ihor Dusaniwsky, appeared in an interview on Yahoo Finance where he discussed the current trading patterns among institutional investors. Dusaniwsky noted that he sees “more leveraging, more asset accumulation, both on the long and the short side by hedge funds” in 2023, relative to 2022. Ihor Dusaniwsky noted that there are some stocks “that are crowded and losing money” and cautioned against them because they can potentially be “squeezable shorts”. Ihor Dusaniwsky also spoke about how he identifies a “squeezable stock” and said that he is basically “looking at losses” since “no one gets out of a profitable trade”. Ihor Dusaniwsky noted that “market momentum plays in both the long and short side” when he spoke about the potential factors that can trigger a short squeeze. Dusaniwsky also spoke about how investors’ attitudes have shifted and noted that investors would buy into profitable companies before, based on business fundamentals. However, now investors think that “this might be a profitable company but the Street hates it” and so they steer clear of the trade. Ihor Dusaniwsky also weighed in on large-cap and mega-cap stocks that are being, both, bought and sold by investors. Ihor Dusaniwsky said that “there’s kind of a market issue here” and there are “less stocks in the mega and large-cap names, where the hedge funds who have a lot more money need to invest their money into”. He further noted that large-cap and mega-cap stocks have an overlap as they are “the most held long and short”. Here are some comments from Ihor Dusaniwsky:

“The scary thing is that, you’ve got guys on both sides of the market. So when we have market news, one side wins and one side loses. You start seeing action, buying, selling, buying to cover short selling, and that really just makes the stock prices of some of these names have these one-day volatilities that really can scare the hell out of some investors.”

Some of the most shorted stocks right now on Wall Street include Kohl’s Corporation (NYSE:KSS), CNX Resources Corporation (NYSE:CNX), and Carvana Co. (NYSE:CVNA). Let’s take a look at these stocks, among others, in detail.

Photo by Roberto Júnior on Unsplash

Our Methodology

We used the stock screener from Yahoo Finance to screen for the most shorted stocks and sifted through the top 100 stocks on the list. We then sourced the hedge fund sentiment for each stock from Insider Monkey’s database of over 900 elite money managers, as of Q4 2022. Finally, we picked the 15 stocks that had the most negative hedge fund sentiment on the margin and came up with the 15 most shorted stocks right now on Wall Street. We have ranked these stocks in ascending order of the number of hedge funds that have stakes in them. Where the number of hedge funds was the same, we used short interest as the tie-breaker. These stocks are ranked in ascending order of both metrics.

15 Most Shorted Stocks Right Now on Wall Street

15. PetMed Express, Inc. (NASDAQ:PETS)

Number of Hedge Fund Holders: 9

Short % of Float (Jan 30, 2023): 26.95%

PetMed Express, Inc. (NASDAQ:PETS) is an American pet pharmacy that sells prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. PetMed Express, Inc. (NASDAQ:PETS) is one of the most shorted stocks on Wall Street right now. As of January 30, 26.95% of the company’s total float has been shorted.

On February 6, PetMed Express, Inc. (NASDAQ:PETS) posted earnings for the fiscal third quarter of 2023. The company missed EPS estimates by $0.20. The company generated a revenue of $58.87 million, down 3.04% year over year and short of expectations by $3.16 million.

PetMed Express, Inc. (NASDAQ:PETS) was held by 9 hedge funds at the close of Q4 2022. The total stakes of these hedge funds amounted to $33.4 million, down from $42.9 million in the preceding quarter with 15 positions. The hedge fund sentiment for the stock is negative.

As of December 31, Citadel Investment Group is the largest investor in PetMed Express, Inc. (NASDAQ:PETS) and has disclosed a position worth $6.91 million in the company.

Some of the stocks that hedge funds have sold and shorted heavily include Kohl’s Corporation (NYSE:KSS), CNX Resources Corporation (NYSE:CNX), and Carvana Co. (NYSE:CVNA).

14. Gevo, Inc. (NASDAQ:GEVO)

Number of Hedge Fund Holders: 11

Short % of Float (Jan 30, 2023): 19.90%

Gevo, Inc. (NASDAQ:GEVO) is a renewable fuels company operating through four divisions: Gevo, Agri-Energy, Renewable Natural Gas, and Net-Zero. This February, Stifel analyst Derrick Whitfield maintained his $5 price target and a Buy rating on Gevo, Inc. (NASDAQ:GEVO).

With a short interest of 19.90% as of January 30, Gevo, Inc. (NASDAQ:GEVO) is one of the most shorted stocks on Wall Street right now.

At the close of Q4 2022, Gevo, Inc. (NASDAQ:GEVO) was a part of 11 investors’ portfolios that disclosed collective positions worth $15.8 million in the company. This is compared to 15 hedge funds in the previous quarter with stakes worth $19.8 million. The hedge fund sentiment for the stock is negative.

As of December 31, Two Sigma Advisors is the most prominent shareholder in Gevo, Inc. (NASDAQ:GEVO) and has disclosed a position worth $2.72 million in the company.

13. Ebix, Inc. (NASDAQ:EBIX)

Number of Hedge Fund Holders: 11

Short % of Float (Jan 30, 2023): 24.18%

Ebix, Inc. (NASDAQ:EBIX) is an American software company that provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, and healthcare industries across the globe. At the end of Q4 2022, 11 hedge funds held stakes in Ebix, Inc. (NASDAQ:EBIX). This is compared to 17 hedge funds in the previous quarter.

On February 23, Craig-Hallum analyst Jeff Van Rhee slashed his price target on Ebix, Inc. (NASDAQ:EBIX) to $40 from $150 and maintained a Buy rating on the shares. Ebix, Inc. (NASDAQ:EBIX) is one of the most shorted stocks on Wall Street right now. As of January 30, 24.18% of the company’s float has been shorted.

As of December 31, D E Shaw is the top shareholder in Ebix, Inc. (NASDAQ:EBIX) and has a position worth $12.7 million in the company.

12. Kymera Therapeutics, Inc. (NASDAQ:KYMR)

Number of Hedge Fund Holders: 15

Short % of Float (Jan 30, 2023): 21.99%

Kymera Therapeutics, Inc. (NASDAQ:KYMR) is a clinical stage biopharmaceutical company that is focused on developing protein degrader therapeutics which utilize the body’s natural protein degradation system. On February 23, Kymera Therapeutics, Inc. (NASDAQ:KYMR) posted earnings for the fiscal fourth quarter of 2022. The company reported a loss per share of $0.59 and generated a revenue of $16.14 million, falling short of expectations by $4.52 million.

With a short interest of 21.99%, as of January 23, Kymera Therapeutics, Inc. (NASDAQ:KYMR) is one of the most shorted stocks on Wall Street right now.

At the close of the fourth quarter of 2022, Kymera Therapeutics, Inc. (NASDAQ:KYMR) was a part of 15 investors’ portfolios, down from 19 investors’ portfolios in the third quarter of 2022. As of December 31, Biotechnology Value Fund / BVF Inc is the most prominent shareholder in the company and has a stake worth $117.12 million.

11. Upstart Holdings, Inc. (NASDAQ:UPST)

Number of Hedge Fund Holders: 16

Short % of Float (Jan 30, 2023): 39.87%

Upstart Holdings, Inc. (NASDAQ:UPST) is an American fintech company that operates an AI-powered cloud-based lending platform in the United States. As of January 30, 39.87% of the company’s float has been shorted and Upstart Holdings, Inc. (NASDAQ:UPST) is the eleventh most shorted stock on Wall Street right now.

On February 14, Upstart Holdings, Inc. (NASDAQ:UPST) reported earnings for the fourth quarter of fiscal 2022. The company’s revenue for the quarter fell by 51.81% year over year and amounted to $146.91 million. The company reported a loss per share of $0.25.

At the end of the fourth quarter of 2022, 16 hedge funds were long Upstart Holdings, Inc. (NASDAQ:UPST) and disclosed collective positions worth $16.2 million in the company. This is compared to 20 hedge funds in the previous quarter with stakes worth $81.4 million.

As of December 31, Coatue Management is the largest stockholder in Upstart Holdings, Inc. (NASDAQ:UPST) and has a position worth $11 million in the company.

10. Camping World Holdings, Inc. (NYSE:CWH)

Number of Hedge Fund Holders: 17

Short % of Float (Jan 30, 2023): 23.98%

Camping World Holdings, Inc. (NYSE:CWH) is an American automotive retail company. The company retails recreational vehicles and offers related products and services. The company has two divisions: Good Sam Services & Plans and RV & Outdoor Retail.

On February 23, BMO Capital lowered its price target on Camping World Holdings, Inc. (NYSE:CWH) to $26 from $30 and maintained a Market Perform rating on the shares.

Camping World Holdings, Inc. (NYSE:CWH) is ranked tenth among the most shorted stocks on Wall Street right now. As of January 30, 23.98% of the company’s float has been shorted.

Camping World Holdings, Inc. (NYSE:CWH) was held by 17 hedge funds at the end of Q4 2022. These hedge funds held collective positions worth $171.8 million in the company, down from $223.9 million in the previous quarter with 22 positions. The hedge fund sentiment for the stock is negative.

As of December 31, Abrams Capital Management is the most prominent investor in Camping World Holdings, Inc. (NYSE:CWH) and has a position worth $114 million in the company.

9. The Children’s Place, Inc. (NASDAQ:PLCE)

Number of Hedge Fund Holders: 17

Short % of Float (Jan 30, 2023): 25.68%

The Children’s Place, Inc. (NASDAQ:PLCE) is a children’s clothing store. The company has two business divisions: The Children’s Place U.S. and The Children’s Place International. At the end of Q4 2022, 17 hedge funds disclosed positions in The Children’s Place, Inc. (NASDAQ:PLCE). This is compared to 21 hedge funds in the third quarter of 2022.

With a short interest of 25.68%, as of January 30, The Children’s Place, Inc. (NASDAQ:PLCE) is one of the most shorted stocks on Wall Street right now. This February, Telsey Advisory analyst Dana Telsey downgraded the stock to Market Perform from Outperform and reiterated her $46 price target on the shares.

As of December 31, Invenomic Capital Management is the largest shareholder in The Children’s Place, Inc. (NASDAQ:PLCE) and has disclosed a position worth $8.76 million in the company.

8. Beam Therapeutics Inc. (NASDAQ:BEAM)

Number of Hedge Fund Holders: 18

Short % of Float (Jan 30, 2023): 20.28%

Beam Therapeutics Inc. (NASDAQ:BEAM) is an American biotechnology company focused on precision genetic medicines. On February 28, the company posted earnings for the fiscal fourth quarter of 2022. The company reported a loss per share of $0.54 and outperformed EPS estimates by $0.80. The company’s revenue for the quarter fell by 60.76% year over year and amounted to $20.04 million. With a short interest of 20.28%, as of January 30, Beam Therapeutics Inc. (NASDAQ:BEAM) is ranked high among the most shorted stocks on Wall Street right now.

Beam Therapeutics Inc. (NASDAQ:BEAM) was spotted on 18 investors’ portfolios at the end of Q4 2022. The total stakes of these funds amounted to $632.1 million. This is compared to 27 hedge funds in the preceding quarter with stakes worth $797.4 million.

As of December 31, Cathie Wood’s ARK Investment Management is the top stockholder in Beam Therapeutics Inc. (NASDAQ:BEAM) and has disclosed a position worth $321.21 million in the company.

7. Allogene Therapeutics, Inc. (NASDAQ:ALLO)

Number of Hedge Fund Holders: 20

Short % of Float (Jan 30, 2023): 38.14%

Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a clinical stage immuno-oncology company. This March, Canaccord analyst John Newman lowered his price target on Allogene Therapeutics, Inc. (NASDAQ:ALLO) to $35 from $55 and reiterated a Buy rating on the shares.

Allogene Therapeutics, Inc. (NASDAQ:ALLO) is one of the most shorted stocks on Wall Street right now. As of January 30, 38.14% of the company’s float has been shorted.

At the end of Q4 2022, 20 hedge funds held stakes in Allogene Therapeutics, Inc. (NASDAQ:ALLO). The total value of these stakes amounted to $118.6 million, down from $190.9 million in the previous quarter with 28 positions. The hedge fund sentiment for the stock is negative.

As of December 31, EcoR1 Capital is the leading investor in Allogene Therapeutics, Inc. (NASDAQ:ALLO) and has a stake worth $28.23 million in the company.

6. Gossamer Bio, Inc. (NASDAQ:GOSS)

Number of Hedge Fund Holders: 22

Short % of Float (Jan 30, 2023): 30.96%

Gossamer Bio, Inc. (NASDAQ:GOSS) is an American clinical-stage biopharmaceutical company. The company is involved in the development and commercialization of therapeutics for immunology, inflammation, and oncology in the United States. At the close of the fourth quarter of 2022, 22 hedge funds were eager on Gossamer Bio, Inc. (NASDAQ:GOSS) and held stakes worth $50.6 million in the company. This is compared to 33 positions in the previous quarter with stakes worth $401.02 million.

On December 8, 2022, H.C. Wainwright analyst Patrick Trucchio slashed his price target on Gossamer Bio, Inc. (NASDAQ:GOSS) to $5 from $25 and maintained a Buy rating on the shares. With a short interest of 30.96%, as of January 30, Gossamer Bio, Inc. (NASDAQ:GOSS) is the sixth most shorted stock on Wall Street right now.

As of December 31, Hillhouse Capital Management is the largest shareholder in Gossamer Bio, Inc. (NASDAQ:GOSS) and has disclosed a position worth $10.79 million in the company.

Some of the most shorted stocks that are popular among elite money managers include Gossamer Bio, Inc. (NASDAQ:GOSS), Kohl’s Corporation (NYSE:KSS), CNX Resources Corporation (NYSE:CNX), and Carvana Co. (NYSE:CVNA).

Click to continue reading and see 5 Most Shorted Stocks Right Now on Wall Street.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

The AI infrastructure supercycle
The onshoring boom driven by Trump-era tariffs
A surge in U.S. LNG exports
And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

Access to our Detailed Report on our AI, Tariffs, and Nuclear Energy Stock with 100+% potential upside within 12 to 24 months
BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
Bonus Content: Premium access to members-only fund manager video interviews
Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up

15 Most Shorted Stocks Right Now on Wall Street

Published on March 3, 2023 at 11:40 am by Omer Farooq in Hedge Funds, News

Analyst’s Take on Shorted Stocks

15 Most Shorted Stocks Right Now on Wall Street

15. PetMed Express, Inc. (NASDAQ:PETS)

14. Gevo, Inc. (NASDAQ:GEVO)

13. Ebix, Inc. (NASDAQ:EBIX)

12. Kymera Therapeutics, Inc. (NASDAQ:KYMR)

11. Upstart Holdings, Inc. (NASDAQ:UPST)

10. Camping World Holdings, Inc. (NYSE:CWH)

9. The Children’s Place, Inc. (NASDAQ:PLCE)

8. Beam Therapeutics Inc. (NASDAQ:BEAM)

7. Allogene Therapeutics, Inc. (NASDAQ:ALLO)

6. Gossamer Bio, Inc. (NASDAQ:GOSS)

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Premium

Log In

Sign Up

15 Most Shorted Stocks Right Now on Wall Street

Published on March 3, 2023 at 11:40 am by Omer Farooq in Hedge Funds, News

Share

Analyst’s Take on Shorted Stocks

15 Most Shorted Stocks Right Now on Wall Street

15. PetMed Express, Inc. (NASDAQ:PETS)

14. Gevo, Inc. (NASDAQ:GEVO)

13. Ebix, Inc. (NASDAQ:EBIX)

12. Kymera Therapeutics, Inc. (NASDAQ:KYMR)

11. Upstart Holdings, Inc. (NASDAQ:UPST)

10. Camping World Holdings, Inc. (NYSE:CWH)

9. The Children’s Place, Inc. (NASDAQ:PLCE)

8. Beam Therapeutics Inc. (NASDAQ:BEAM)

7. Allogene Therapeutics, Inc. (NASDAQ:ALLO)

6. Gossamer Bio, Inc. (NASDAQ:GOSS)

Share

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up: